Globe Commercial (540266)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price of ₹23.20 versus book value of ₹857 gives a P/B of just 0.03, an extreme margin of safety if book value is trustworthy.
• Strong recent growth: sales up 25.11% and profit up 63.04%, with latest quarter sales of ₹221 Cr and net profit of ₹7 Cr.
• Piotroski F-Score of 7/9 indicates improving fundamentals across profitability, leverage, and efficiency.
• PEG of 0.01 suggests the market is pricing in little growth despite strong recent momentum.

Concerns

• Extremely low ROE of 1.15% suggests the large book value is not generating meaningful shareholder returns.
• P/E of 0.36 and P/B of 0.03 are so extreme that data errors or asset quality issues are more likely than a simple bargain.
• No dividend yield, promoter holding not disclosed, and a microcap market cap of ₹14 Cr raise governance and liquidity concerns.
• Trading and distribution business likely has a thin moat and limited pricing power, making earnings durability questionable.

AI Analysis

At first glance, this looks like a Graham special: price ₹23.20 against book value ₹857, a P/B of 0.03, and a P/E of 0.36. The entire business is being valued at just ₹14 crore. But a low multiple is not the same as a bargain. I must ask: is that book value real, and can it earn a return? The ROE is only 1.15%, so the huge book value is not producing much profit. The recent momentum is impressive — sales up 25.11%, profit up 63.04%, and the latest quarter shows ₹221 crore in sales and ₹7 crore net profit. The Piotroski F-Score of 7/9 also suggests improving fundamentals. Yet this is a trading and distribution business in a competitive, low-moat industry. Market cap is tiny, promoter holding is not disclosed, and there is no dividend. The 52-week range of ₹12.40 to ₹36.30 tells me this is a volatile microcap. When ratios look too good, the error is often in the data. A P/B of 0.03 is priced for collapse or a very messy balance sheet. I cannot treat this as a quality compounder; I would treat it as an asset play with a growth kicker. Before acting, I would verify the composition of book value, receivables, inventory, and management integrity. If every rupee of book value is genuinely worth a rupee, the upside is huge. If the assets are stale or overstated, this could trap patient investors. Mr. Market is fearful — price is well below the 52-week high — but fear alone is not enough. I need proof.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer